| Product Name | MF | CAS | Details |
|---|
| 4-Hydroxy Omeprazole Sulfide | C16H17N3O2S | 103876-98-8 | Details |
| 5-METHOXY-2-[((4-METHOXY-3,5-DIMETHYL-1-OXIDO-2-PYRIDINYL)METHYL)SULFINYL]-BENZIMIDAZOLE | C17H19N3O4S | 176219-04-8 | Details |
| (3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid sodium salt | C25H36CaFN3O7S | 1714147-47-3 | Details |
| (+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride | C15H14ClNO2S.ClH | 144750-42-5 | Details |
| Pyridine, 4-chloro-2-(chloromethyl)-3,5-dimethyl-, hydrochloride | C8H10Cl3N | 143016-68-6 | Details |
| 5-METHOXY-2-[(3,5-DIMETHYL-2-PYRIDINYL)-METHYLSULFINYL]-BENZIMIDAZOLE | C16H17N3O2S | 110374-16-8 | Details |
| (1R)-3-(dimethylamino)-1-thiophen-2-ylpropan-1-ol | C9H15NOS | 132335-49-0 | Details |
| 2-(4-nitrophenyl)ethyl methyl ether | C9H11NO3 | 69628-98-4 | Details |
| 4-Desmethyl-2-methyl Celecoxib;4-[5-(2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide | C17H14F3N3O2S | 170569-99-0 | Details |
| 4-(2-methoxyethyl)aniline | C9H13NO | 84803-56-5 | Details |
| 3-(Dimethylamino)-1-(3-thienyl)-1-propanone Hydrochloride | C9H14ClNOS | 14994-02-6 | Details |
| Pentanamide,5-chloro- | C5H10ClNO | 2455-05-2 | Details |
| METHYL 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE | C9H11NO3 | 58298-68-3 | Details |
| Mirabegron impurity D | C26H28N6O3S2 | Details |
| N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-2-amine | C18H20ClNOS | 1104890-90-5 | Details |
| R-DULOXETINE Oxalate | C18H19NOS | 116539-60-7 | Details |
| (E)-5-(2, 5-dimethyl-4-(prop-1-enyl)phenoxy)-2, 2-dimethylpentanoic acid | C18H26O3 | 500904-61-0 | Details |
| Mixture of N-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole and N'-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole | C26H30N4O4S | 1346599-85-6 | Details |
| 1-chloro-3-(propan-2-ylamino)propan-2-ol,hydrochloride | C6H15Cl2NO | 39552-14-2 | Details |
| 5-(4-Bromophenyl)-4,6-dichloropyrimidine | C10H5BrCl2N2 | 146533-41-7 | Details |
| (S)-2-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)aMino)-3- Methylbutanoic acid | C19H21N5O2 | 676129-92-3 | Details |
| rac-α-[2-(Dimethylamino)ethyl]-3-thiophenemethanol | C9H15NOS | 116817-84-6 | Details |
| Sitagliptin Fumarate Adduct(Sitagliptin Impurity FP-A) | C20H19F6N5O5 | 2088771-60-0 | Details |
| N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine Oxalate | C20H21NO5S | 116817-28-8 | Details |
| 3-Morpholinone, 4-(2-aMinophenyl)- | C10H12N2O2 | 1082588-73-5 | Details |
| 3,5-DIMETHYL 2-CHLORMETHYL PYRIDINE.HCL | C8H11Cl2N | 73590-93-9 | Details |
| 4-Butoxybutyl alcohol | C8H18O2 | 4161-24-4 | Details |
| 4-[(1S)-3-(Methylamino)-1-(2-thienyl)propoxy]-1-naphthaleno | C18H19NO2S | 662149-13-5 | Details |
| 1-Chloro-3-isopropylamino-2-propanol | C6H14ClNO | 50666-68-7 | Details |
| N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-3-amine HCl | C18H19NOS | 116817-27-7 | Details |
| 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide | C26H27N5O4 | 1686149-74-5 | Details |
| 1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide | C26H27N5O4 | 2098457-92-0 | Details |
| 5-chlorohexanoyl chloride | C6H10Cl2O | 99585-01-0 | Details |
| Difluoro Atorvastatin Acetonide tert-Butyl Ester | C40H46F2N2O5 | 693793-87-2 | Details |
| Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride | C16H16ClNO2S.ClH | 144750-52-7 | Details |
| Rosuvastatin Calcium Impurity C (EP) | C22H26FN3O6S | 1422619-13-3 | Details |
| Atorvastatin EP IMpurity A | C33H35CaN2O5+ | 433289-83-9 | Details |
| (S)-Sitagliptin Phosphate | C16H16F6N5O5P | 823817-58-9 | Details |
| (S)-4-Desmethoxy-4-chloro Omeprazole | C16H16ClN3O2S | 863029-89-4 | Details |
| methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate | C16H18ClNO6S2 | 120202-71-3 | Details |
| (2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | C16H14F3N5O | 182230-43-9 | Details |
| N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide | C22H26FN3O5S | 503610-43-3 | Details |
| Atorvastatin EP IMpurity C | C33H36CaF2N2O5 | 693793-53-2 | Details |
| 2-[[(3,5-DiMethyl-2-pyridinyl)Methyl]thio]-6-Methoxy-1H-benziMidazole | C16H17N3OS | 704910-89-4 | Details |
| 5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-7a-hydroxy-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one | C18H18FNO3S | 947502-66-1 | Details |
| 2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid | C10H10N4O3S2 | 2036283-13-1 | Details |
| Omeprazole Sulfone N-Oxide | C17H19N3O5S | 158812-85-2 | Details |
| Rosuvastatin EP IMpurity E Calcium Salt | Details |
| 4-Desmethoxy-4-chloro Omeprazole Sulfide | C16H16ClN3OS | 220757-74-4 | Details |
| Defluoro Atorvastatin Acetonide tert-Butyl Ester | C40H48N2O5 | 1105067-91-1 | Details |
| Metoprolol EP IMpurity M | C9H22N2O | 343785-33-1 | Details |
| 4,7-Methano-1H-isoindole-1,3(2H)-dione,2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-methyl]cyclohexyl] methyl]hexahydro-,(3aR,4R,7S,7aS) | C28H36N4O2S | 1318074-25-7 | Details |
| Rosuvastatin EP impurity B | Details |
| (S)-3-[1-(methylamino)ethyl]-phenyl N-ethyl-N-methyl-carbamate | C13H20N2O2 | 923035-05-6 | Details |
| Pentanoyl chloride, 5-chloro-4-methyl- | C6H10Cl2O | 813452-05-0 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||